icon-folder.gif   Conference Reports for NATAP  
 
  Paris Special EASL Meeting
Pais, France
September 23-24, 2016
Back grey_arrow_rt.gif
 
 
 
Short duration treatment with AL-335 and odalasvir (ODV), with or without simeprevir (SMV), in treatment naïve patients with hepatitis C virus (HCV) genotype (GT) 1 infection
 
 
  Reported by Jules Levin
EASL Special Conference Paris, France Sept 23 2016
 
Ed Gane1, Matthew W. McClure2, David Apelian3, Chris Westland2, Thomas N. Kakuda2, Sushmita Chanda2, Lawrence Blatt2, Leo Beigelman2, David B. Smith2, John Fry2 1. New Zealand Liver Transplant Unit, Auckland City Hospital, New Zealand; 2. Alios BioPharma Inc, South San Francisco, CA, United States; 3. Achillion Pharmaceuticals, New Haven, CT, United States

IAC1

IAC2

IAC3

IAC4

IAC5

IAC6

IAC7

IAC8